Found 4366 articles for: ""
Efficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis
December 2023 | Volume 22 | Issue 12 | Original Article | 1160 | Copyright © December 2023
Background: Porokeratosis is a group of disorders characterized by aberrant skin keratinization secondary to genetic alterations in the mevalonate pathway, which participates in ...
Read MoreInternational Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting
December 2023 | Volume 22 | Issue 12 | Original Article | 1153 | Copyright © December 2023
Background: The International Dermatology Outcome Measures (IDEOM) is a non-profit organization dedicated to the advancement of evidence-based, consensus-driven outcome measures ...
Read MoreInnate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review
December 2023 | Volume 22 | Issue 12 | Original Article | 1197 | Copyright © December 2023
Background: Candida albicans is an opportunistic pathogenic yeast commensal in human mucosa. In individuals with compromised immune systems, it can present as chronic mu...
Read MoreUnderrepresented Groups and Perceived Educational Barriers for Residency and Fellowship Success
December 2023 | Volume 22 | Issue 12 | Original Article | 1210 | Copyright © December 2023
Background: The study aimed to compare barriers perceived by medical students and resident physicians identifying as of underrepresented groups in medicine (UIM) and/or as sexual...
Read MoreRecombinant Zoster Vaccine Reduces 3-Year Cardiovascular Risk: Insights From a Multi-Centered Database
December 2023 | Volume 22 | Issue 12 | Original Article | 1178 | Copyright © December 2023
Background: Herpes zoster increases the risk for stroke and myocardial infarction. Zoster vaccination's impact on this risk is understudied. This retrospective work sought to det...
Read MoreTopical Stabilized Super-Oxidized Hypochlorous Acid for Wound Healing in Hair Restoration Surgery: A Real-Time Usage-Controlled Trial Evaluating Safety, Efficacy, and Tolerability
December 2023 | Volume 22 | Issue 12 | Original Article | 1191 | Copyright © December 2023
Objective: Assess the perceived efficacy of stabilized, super-oxidized hypochlorous acid (HOCl) in hair transplant surgical procedures intraoperative and postoperative.Read More Unique Usages of Dehydrated Human Amnion Chorion Membrane Allografts in Dermatology
December 2023 | Volume 22 | Issue 12 | Features | 1228 | Copyright © December 2023
Dehydrated human amnion chorion membrane (dHACM) allografts are synthetic skin substitutes derived from placental tissue. dHACM allografts are used for replacing lost or damaged dermal tissue, as...
Read MoreA Pilot Study to Evaluate the Efficacy and Tolerability of a Topical Combination Serum for the Improvement of Aged Skin
December 2023 | Volume 22 | Issue 12 | Original Article | 1204 | Copyright © December 2023
Background: With intrinsic aging, the epidermis becomes thinner and fine wrinkles appear. Extrinsic aging, or photoaging, is characterized by deep wrinkles, skin laxity, and hype...
Read More14-Gauge Coaxial Bone Needle Leads to Superior Results When Injecting Calcinosis Cutis
December 2023 | Volume 22 | Issue 12 | Editorials | e47 | Copyright © December 2023
Mpox "Monkeypox" Virus: The Importance of Inclusive Imagery to Prevent Disease Stigma
December 2023 | Volume 22 | Issue 12 | Editorials | 1235 | Copyright © December 2023
Since the initial coverage of the monkeypox virus, there has been debate among physicians over how to responsibly communicate public health information without harming historically marginalized commun...
Read MoreTopical Moisturizer Meaningfully Reduces Disease Severity in Atopic Patients With Xerosis
December 2023 | Volume 22 | Issue 12 | Editorials | e51 | Copyright © December 2023
Background: Repairing the epidermal barrier is critically important in atopic dermatitis (AD), but the effect of moisturizer on quality of life (QOL) is not well characterized.&n...
Read MorePerceptions of United States Dermatology Resident Program Directors Regarding Oral Mucosal Dermatology Training
December 2023 | Volume 22 | Issue 12 | Editorials | e36 | Copyright © December 2023
A Case Series on the Use of Brentuximab Vedotin for the Treatment of Mycosis Fungoides
December 2023 | Volume 22 | Issue 12 | Features | e33 | Copyright © December 2023
Background: Brentuximab vedotin (BV) is an anti-CD30 monoclonal antibody that appears to be more effective against CD30-expressing cutaneous T-cell lymphoma (CTCL) compared to cu...
Read MoreHome Is Where the Match Is: Mentorship and Dermatology Residency Match Trends Before and During the COVID-19 Pandemic
December 2023 | Volume 22 | Issue 12 | Editorials | e44 | Copyright © December 2023
Tocilizumab Treatment in COVID-19 Patients: Comparing Cutaneous Disease and Adverse Drug Effects
December 2023 | Volume 22 | Issue 12 | Editorials | e42 | Copyright © December 2023
Actemra (tocilizumab) received emergency use authorization for the treatment of coronavirus disease 2019 (COVID-19) in June 2021. Literature has linked numerous cutaneous adverse effects to tocil...
Read MoreThe Persistence of Nystatin Use for Dermatophyte Infections
December 2023 | Volume 22 | Issue 12 | Editorials | e49 | Copyright © December 2023
Background: Despite the limited use of nystatin for tinea infections, physicians may continue to use it.Methods: We assessed the National Ambulatory...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (NECOM) 3: A Practical Algorithm for Acute Radiation Dermatitis Management for Cancer Patients Receiving Radiation Therapy
November 2023 | Volume 22 | Issue 11 | Department | SF400354s1 | Copyright © November 2023
Background: In the Nordic European countries in 2020, cancer diagnoses accounted for 175,925 patients. About 50% of cancer patients receive radiation therapy (RT), which may...
Read MoreFULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (USCOM) III: A Multidisciplinary-Guided Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events in Cancer Patients
November 2023 | Volume 22 | Issue 11 | Department | SF389716s1 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MoreINDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF389716s4 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MorePlatelet-Rich Plasma Across the Spectrum of Alopecias: Where Are We Now?
November 2023 | Volume 22 | Issue 11 | Features | 1134 | Copyright © November 2023
Media and other results for: ""